James M. Ridgeway

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 1. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Discovery and Variation of the 5-Keto Substituent

John M. Janusz, Patricia A. Young, James M. Ridgeway et al. · Journal of Medicinal Chemistry · 1998 · 53 citations · Full text

Pharmacotherapy, New Cyclooxygenase-2/5-lipoxygenase Inhibitors, Pharmaceutical Chemistry +16

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Variations at the 5 Position

John M. Janusz, Patricia A. Young, James M. Ridgeway et al. · Journal of Medicinal Chemistry · 1998 · 44 citations · Full text

Bioorganic Chemistry, Gastrointestinal Pharmacology, Dual Cyclooxygenase +19

Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias

C. M. Jackson, Benjamin E. Blass, Keith R. Coburn et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 35 citations · Full text

Human Kv1.5, Medicine, Atrial Arrhythmias +7

Total Synthesis of Coriandrin

George A. Kraus, James M. Ridgeway · The Journal of Organic Chemistry · 1994 · 20 citations

Altmetrics, Information Retrieval, Content Analysis +13

Solution phase synthesis of imidazo[1,2-b]pyrazol-2-one, an interesting 5,5-fused heterocyclic ring system

Benjamin E. Blass, Anil Srivastava, Keith R. Coburn et al. · Tetrahedron Letters · 2003 · 12 citations

Organic Chemistry, Solution Phase Synthesis, Heterocyclic +1